| 1 |
28211024 | Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database. | 2017 Jun |
1 |
| 2 |
28751099 | Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. | 2017 Aug |
1 |
| 3 |
28906152 | Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dimethyl fumarate: a real-world study. | 2017 Dec |
2 |
| 4 |
27252601 | Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis. | 2016 May-Jun |
2 |
| 5 |
27645339 | Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis. | 2016 Sep |
1 |
| 6 |
24759080 | New management algorithms in multiple sclerosis. | 2014 Jun |
1 |
| 7 |
25182864 | Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. | 2014 Sep |
1 |